DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS

View On IC.GC.CA

ABANDONED SECTION 40(3)

on 15 Jul 2015

Last Applicant/ Owned by

ASTRAZENECA AB

Vastra Malarehamnen 9 SödertäljeSE-151 85

Serial Number

1583727 filed on 26^th Jun 2012

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

M5X1G5

DECLARE DAPAGLIFLOZIN EVALUATION OF CARDIOVASCULAR EVENTS

Trademark usage description

medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

CIPO Classification Code

Nice

1583727

Trademark

Action Taken	Status
Submitted for opposition 7 on 15^th Jul 2015	Abandoned - Subsection 40(3)
Submitted for opposition 80 on 8^th May 2014	Change of Title Registered
Submitted for opposition 51 on 17^th May 2013	Allowance Notice Sent
Submitted for opposition 50 on 17^th May 2013	Allowed
Submitted for opposition 42 on 30^th Jan 2013	Advertised
Submitted for opposition 26 on 24^th Jan 2013	Approved
Submitted for opposition 27 on 4^th Dec 2012	Approval Notice Sent
Submitted for opposition 22 on 4^th Dec 2012	Search Recorded
Submitted for opposition 31 on 10^th Jul 2012	Formalized
Submitted for opposition 1 on 27^th Jun 2012	Created